vendredi 10 avril 2015

Onco Actu du 10 avril 2015


Les étoiles de couleur jaune signalent des articles dont la lecture est en priorité suggérée (1*) ou recommandée (3*).

1. Biologie

Breast cancer cells may spread by mimicking blood vessels [Cancer Research UK]

Clam Cancer Rips Along Atlantic Coast [The Scientist]

Selfish Shellfish Cells Cause Contagious Clam Cancer [Phenomena]

1.1 Biologie - Gènes

UTSW researchers lead collaborative charge to uncover genetic diversity of pancreatic cancer [National Cancer Institute]

3.1 Tabac

Swedish tobacco company to challenge FDA demands for warning labels [The Guardian]

Swedish Company Asks F.D.A. to Remove Warnings From Smokeless Tobacco Product [NY Times]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

New FDA Program to Expedite the Approval of 'Breakthrough' Medical Devices [RAPS]

4.9 Dép., diag. & prono. - Sein

Genetic test could help identify breast cancer risk [Cancer Research UK]

5. Traitements

Review highlights potential of cancer immunotherapy plus targeted therapy [MD Anderson Cancer Center]

Comparing immunotherapy to other cancer weapons []

Cancer Immunotherapist [The Scientist]

To Each His Own [The Scientist]

5.2.1 Pharma - Partenariats

Merck and Pfizer to co-promote cancer drug [Pharmafile]

5.3 Traitements - FDA, EMA,...

Exelixis Stock Rises Today Following FDA Fast Track Designation [TheStreet]

Exelixis’ Cabozantinib Granted Fast Track Designation by FDA For Advanced Renal Cell Carcinoma [Exelixis]

5.4 Traitements - Economie

Big Pharma-backed Dutch immuno-oncology player eyes €100M Nasdaq IPO [FierceBiotech]

Fidelity CEO taps personal fortune for bets on cancer-related IPOs [Reuters]

6.10 Politiques

Bernard Merkel: Measuring the performance of health systems—a troubled history [BMJ Blogs]

6.11 Patients

Cancer survivors can have a fulfilling sex life – we need to talk about how [The Conversation]

6.4 Médico-éco

Improving cross-sector comparisons: Beyond QALY [Medical Research Council]

6.6 Publications

Study by deceased award-winning cancer researcher retracted because some patients were "invented" [Retraction Watch]

6.9 Controverses

Hospital in Ashya King case reveals 'outpouring of hatred' directed at staff [The Guardian]